MRI (magnetic resonance imaging) could screen for recurrence of rectal cancer
This article was originally published in Clinica
MRI could be used to screen patients at high risk of recurrent rectal cancer who would benefit from preoperative radiotherapy, according to a Dutch study. The findings, reported at the ECR meeting, are based on the ability of the technique to accurately predict the distance of a tumour from a region known as the circumferential resection margin. If a tumour invades this margin, patients are at risk of local cancer recurrence, said Dr Beets-Tan, study leader at the University of Maastricht in the Netherlands.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.